Literature DB >> 22014810

Ex vivo ultrasound control of resection margins during partial nephrectomy.

Arnaud Doerfler1, Yannick Cerantola, Jean-Yves Meuwly, Benoît Lhermitte, Henri Bensadoun, Patrice Jichlinski.   

Abstract

PURPOSE: Surgery remains the treatment of choice for localized renal neoplasms. While radical nephrectomy was long considered the gold standard, partial nephrectomy has equivalent oncological results for small tumors. The role of negative surgical margins continues to be debated. Intraoperative frozen section analysis is expensive and time-consuming. We assessed the feasibility of intraoperative ex vivo ultrasound of resection margins in patients undergoing partial nephrectomy and its correlation with margin status on definitive pathological evaluation.
MATERIALS AND METHODS: A study was done at 2 institutions from February 2008 to March 2011. Patients undergoing partial nephrectomy for T1-T2 renal tumors were included in analysis. Partial nephrectomy was done by a standardized minimal healthy tissue margin technique. After resection the specimen was kept in saline and tumor margin status was immediately determined by ex vivo ultrasound. Sequential images were obtained to evaluate the whole tumor pseudocapsule. Results were compared with margin status on definitive pathological evaluation.
RESULTS: A total of 19 men and 14 women with a mean ± SD age of 62 ± 11 years were included in analysis. Intraoperative ex vivo ultrasound revealed negative surgical margins in 30 cases and positive margins in 2 while it could not be done in 1. Final pathological results revealed negative margins in all except 1 case. Ultrasound sensitivity and specificity were 100% and 97%, respectively. Median ultrasound duration was 1 minute. Mean tumor and margin size was 3.6 ± 2.2 cm and 1.5 ± 0.7 mm, respectively.
CONCLUSIONS: Intraoperative ex vivo ultrasound of resection margins in patients undergoing partial nephrectomy is feasible and efficient. Large sample studies are needed to confirm its promising accuracy to determine margin status. Copyright Â
© 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22014810     DOI: 10.1016/j.juro.2011.07.100

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Surgical planning and manual image fusion based on 3D model facilitate laparoscopic partial nephrectomy for intrarenal tumors.

Authors:  Yuanbo Chen; Hulin Li; Dingtao Wu; Keming Bi; Chunxiao Liu
Journal:  World J Urol       Date:  2013-12-12       Impact factor: 4.226

2.  Intraoperative and surgical specimen (ex vivo) ultrasound in the assessment of margins at partial nephrectomy.

Authors:  R Veeratterapillay; A Bromby; A Patel; A Sakthivel; A Abdelbakhy; B D Gowda; A Mutton; S Nagarajan; G P Naisby; A Bhatti
Journal:  Int Urol Nephrol       Date:  2015-08-13       Impact factor: 2.370

3.  Intraoperative ultrasound control of surgical margins during partial nephrectomy.

Authors:  Feras M Alharbi; Charles K Chahwan; Sophie G Le Gal; Kerem M Guleryuz; Xavier P Tillou; Arnaud P Doerfler
Journal:  Urol Ann       Date:  2016 Oct-Dec

4.  Application of intraoperative ultrasonography in retroperitoneal laparoscopic partial nephrectomy: A single-center experience of recent 199 cases.

Authors:  Feiya Yang; Sai Liu; Lianjie Mou; Liyuan Wu; Xuesong Li; Nianzeng Xing
Journal:  Endosc Ultrasound       Date:  2019 Mar-Apr       Impact factor: 5.628

5.  MRI as a tool to assess surgical margins and pseudocapsule features directly following partial nephrectomy for small renal masses.

Authors:  Tim J van Oostenbrugge; Willemien Runneboom; Elise Bekers; Jan Heidkamp; Johan F Langenhuijsen; Andor Veltien; Arie Maat; Peter F A Mulders; Christina A Hulsbergen-van de Kaa; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2018-07-24       Impact factor: 5.315

6.  Visible near infrared reflectance molecular chemical imaging of human ex vivo carcinomas and murine in vivo carcinomas.

Authors:  Shona Stewart; Marlena Darr; Heather Gomer; Aaron Smith; Arash Samiei; James Christopher Post; Ralph J Miller; John Lyne; Jeffrey Cohen; Patrick J Treado
Journal:  J Biomed Opt       Date:  2020-02       Impact factor: 3.170

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.